Eleventh International Symposium HEART FAILURE & Co. MORTE IMPROVVISA SUDDEN DEATH Reggia di Caserta, 29-30 aprile 2011 Lamiloidosi: il danno cardiaco.

Slides:



Advertisements
Similar presentations
Donors Per Million Population
Advertisements

1 A B C
Circle Theorems Bingo!. Use any 9 of these numbers 105 o 240 o 55 o 14 o 65 o 50 o 90 o 45 o 60 o 40 o 110 o 155 o 15 o 74 o 120 o 12 o.
Maenne Okunola Pharm D. Candidate: University of Georgia June 2012 Preceptor: Dr. Ali Rahimi.
Allogeneic Transplant Following Brentuximab Vedotin Treatment in Patients with Relapsed or Refractory CD30+ Lymphomas Illidge T et al. Proc ASH 2011;Abstract.
Treatment of Hypertension
/ /17 32/ / /
International Society for Heart and Lung Transplantation 2010 Annual Report International Society for Heart and Lung Transplantation: A Forum that Includes.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
LUNG TRANSPLANTATION Pediatric Recipients 2011 ISHLT J Heart Lung Transplant Oct; 30 (10):
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26.
THE COMMONWEALTH FUND Figure 1. Health Insurance Coverage and Uninsured Trends Data: Analysis of the U.S. Census Bureau, Current Population Survey Annual.
Heart Disease and Stroke Statistics 2011 Update 1.
CALENDAR.
2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt ShapesPatterns Counting Number.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2012 Summary Slides SUM12_1.ppt.
Hellen Muttai, MBChB, MPH Clinical Care Manager
L. Wu, MD; C.P. Allaart, MD, PhD; G.J. de Roest, MD; M.L. Hendriks, MA; A.C. van Rossum, MD, PhD; C.C. de Cock MD, PhD ACC Scientific Sessions, San Francisco,
Area of triangles.
Making Landmark or Friendly Numbers (Multiplication)
1..
ROCKET-AF Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial.
Primary Care Education Progam. FAMILY PRACTITIONERS: Dr. Carl Fournier, Montreal, QC Dr. Peter Lin, Toronto, ON Dr. Vinod Patel, St. John’s, NFLD Dr.
Chris Bonnett, MHSc, PhD (Cand.) H3 Consulting, Guelph Managing Chronic Disease Can it work at work?
Multiple Myeloma Serena Ezzeddine Morning Report May 30, 2009.
Sets Sets © 2005 Richard A. Medeiros next Patterns.
Echocardiography of Cardiac Amyloidosis
Before Between After.
Peripheral Arterial Disease: missed opportunity for cardiovascular intervention Subhash Banerjee, MD Chief, Division of Cardiology VA North Texas Healthcare.
Housing and Support Sub-Group Partnership Board Report June 2012.
Subtraction: Adding UP
ADDING UP. CATEGORY 1 Adding Up strategy : The whole number is a multiple of ten or one hundred. The subtrahend is close to a multiple of ten or a landmark.
Point de départ Numbers in French follow patterns, as they do in English. First, learn the numbers 0–30. The patterns they follow will help you learn.
Metabolic Syndrome and Obesity in Peripheral Arterial Disease
Dr. Abdulkareem Alsuwaida Associate Professor King Saud University Hemodialysis Symposium February 2014 Al Madinah AlMunawwarah.
Static Equilibrium; Elasticity and Fracture
RENAAL Baseline Characteristics (I) Age, years Male, % Female, % Race, % Asian Black Caucasian Hispanic Other Systolic (mmHg) Diastolic (mmHg) BMI (kg/m.
Fourth Quarter Oklahoma Data (October-December 2011)
Nutrition Interventions in the Treatment of Obesity Dana White, MS, RD, LDN October 25, 2013.
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Case report no. 9. Recurrence of amyloid in a kidney allograft Eva Honsová Institute for Clinical and Experimental Medicine Prague, Czech Republic.
Nicole Rollins.  68 y/o man was referred to cardiology in 2007 for worsening DOE and fatigue  Echocardiogram showed decreased systolic function, EF.
Waldenstrom’s Macroglobulinemia
QUIZ OF THE WEEK By .. Shada AlGhamdi.
Amyloidosis Dr Hisham Alkhalidi. AMYLOIDOSIS Amyloid is a pathologic proteinaceous substance, deposited between cells in various tissues and organs of.
Amyloidosis Dr. Amitabha Basu.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
Cardiomyopathy By: Sachelle Martin.
Protein conformational disorders Amyloid Alice Skoumalová.
Update of Amyloidosis in Korea
Pathologic Diagnosis in Amyloidosis
Immune Disorders: HLA and Disease Associations and Amyloidosis
Biochemical and genetic evaluation in amyloidosis
Amyloidosis By:Dental Tutotr.. Amyloidosis Extracellular deposition of fibrillar proteinaceous substance called amyloid – a ‘ waxy substance ’ composed.
AMYLOIDOSIS. Extra cellular deposition of fibrillar proteinaceous substance; amyloid. Misnomer= meaning starch-like; Affected organs C/S stained brown.
Amyloidosis.
Dr Vishal Saxena MBBS,MD(Path),FICMR
ILOs of the fourth lecture
AG10-201: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of AG10 versus Placebo in ATTR-CM Background Primary Endpoints Key Exclusion Criteria.
The Amyloidoses Douglas A. Stahura 4/7/99.
AMYLOID AND AF: WHAT ARE WE MISSING?
New Clinical Insights Into the Pathology of Amyloidosis
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Alect2 amyloidosis: primum non nocere (first, do no harm)
Volume 82, Issue 2, Pages (July 2012)
Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis by Duncan B. Richards, Louise M. Cookson,
Presentation transcript:

Eleventh International Symposium HEART FAILURE & Co. MORTE IMPROVVISA SUDDEN DEATH Reggia di Caserta, aprile 2011 Lamiloidosi: il danno cardiaco e le conseguenze C. Quarta, C. Rapezzi

.. an infiltrative CMP that looks like hypertrophic or hypertensive heart disease..

Apo A immunoglobulin Lysozime TTR

Terminology and Classification of Amyloidoses Amyloid protein AL ATTR AA A ß 2 M AApo AII AFib Alys …. Aß APrP Syndrome or involved tissue Primary / Myeloma associated Familial (PAF) Senile (wilde type TTR) Secondary, reactive Hemodyalisis associated Familial …. Alzheimers desease, aging Spongioform encephalopathies Precursor immunoglobulin light chain Transthyretin Serum AA ß 2 microglobulin Apolipoprotein AII Fibrinogen chain Lysozyme …. Aß protein precursor Prion protein

Amyloid Heart Disease: Therapeutic Strategies Heart & liver transplantation high dose chemotherapy autologous stem cell transplantation Hereditary ATTR Liver transplantation chemotherapy AL heart transplantation new stabilizer drugs SSA treatment of heart failure heart transplantation

AL (n=157) ATTR (n=61) SSA (n=15) P Value Restrictive filling pattern, n (%) 82/150 (55)22/59 (37)4/14 (29)0.024 Dip-plateau morphology of RV pressure tracing, n (%) 1 (2)1 (3)1/12 (8)0.329 Rapezzi et al, Circulation 2009:120:

CONIGLIO

Perugini et al, Heart 2006;92:

Baseline characteristics of pts with amyloidotic CMP (Bologna & Pavia, n=233) AL (n=157) SSA (n=15) ATTR (n=61) p Value LBBB, n (%)6/146 (4)6 (40)4/60 (7)<0.001 Total QRS score, mV92 ± ± ± 34<0.001 Low QRS voltage, n (%)88/146 (60)6 (40)15/60 (25)<0.001 Any infarct pattern, %101/146 (69)10 (66)41/59 (69)0.98 LV mass among men (g)339 ± ± ± 150< Diastolic IVS (mm)16 ± 320 ± 417 ± 4< LV ejection fraction (%)53 ± 1344 ± 1558 ± 13< Restrictive filling pattern, n (%) 82/150 (55)4/14 (29)22/59 (37)0.02 Rapezzi et al, Circulation 2009;120:

OVERALL SURVIVAL Rapezzi et al, Circulation 2009;120: MACE FREE SURVIVAL

Vascular localization AL 79% ATTR 21% SSA 0% p<0,0001 Inflammation AL 14% ATTR 3% SSA 33% p 0,014 Rapezzi et al, Circulation 2009;120:

Direct toxic effect of circulating light chains Coronary (microvascular) involvement Duration/rapidity of amyloid accumulation ……… Different prognosis and functional impairment

Sudden death ?